No abstract

A suite of amphiphilic siderophores, loihichelins A-F, were isolated from cultures of the marine bacterium Halomonas sp. LOB-5. This heterotrophic Mn(II)-oxidizing bacterium was recently isolated from the partially weathered surfaces of submarine glassy pillow basalts and associated hydrothermal flocs of iron oxides collected from the southern rift zone of Loihi Seamount east of Hawai’i. The loihichelins contain a hydrophilic head group consisting of an octapeptide comprised of D-threo-β-hydroxyaspartic acid, D-serine, L-glutamine, L-serine, L-N(δ)-acetyl-N(δ)-hydroxy ornithine, dehydroamino-2-butyric acid, D-serine and cyclic N(δ)-hydroxy-D-ornithine, appended by one of a series of fatty acids ranging from decanoic acid to tetradecanoic acid. The structure of loihichelin C was determined by a combination of amino acid and fatty acid analyses, tandem mass spectrometry and NMR spectroscopy. The structures of the other loihichelins were inferred from the amino acid and fatty acid analyses, and tandem mass spectrometry. The role of these siderophores in sequestering Fe(III) released during basaltic rock weathering, as well as their potential role in the promotion of Mn(II) and Fe(II) oxidation, is of considerable interest.

Plicatamide (Phe-Phe-His-Leu-His-Phe-His-dc⌬DOPA), where dc⌬DOPA represents decarboxy-(E)-␣,␤-dehydro-3,4-dihydroxyphenylalanine, is a potently antimicrobial octapeptide from the blood cells of the solitary tunicate, Styela plicata. Wild type and methicillin-resistant Staphylococcus aureus (MRSA) responded to plicatamide exposure with a massive potassium efflux that began within seconds. Soon thereafter, treated bacteria largely ceased consuming oxygen, and most became nonviable. Native plicatamide also formed cation-selective channels in model lipid bilayers composed of bacterial lipids. Methicillin-resistant S. aureus treated with plicatamide for 5 min contained prominent mesosomes as well as multiple, small dome-shaped surface protrusions that suggested the involvement of osmotic forces in its antimicrobial effects. To ascertain the contribution of the C-terminal dc⌬DOPA residue to antimicrobial activity, we synthesized several analogues of plicatamide that lacked it. One of these peptides, PL-101 (Phe-Phe-His-Leu-His-Phe-HisTyr-amide), closely resembled native plicatamide in its antimicrobial activity and its ability to induce potassium efflux. Plicatamide was potently hemolytic for human red blood cells but did not lyse ovine erythrocytes. The small size, rapid action, and potent anti-staphylococcal activity of plicatamide and PL-101 make them intriguing subjects for future antimicrobial peptide design.Phe-Phe-His-Leu-His-Phe-His-dc⌬DOPA (plicatamide) 1 is a modified octapeptide found in the hemocytes of Styela plicata (1). In the preceding sequence, dc⌬DOPA indicates decarboxy-(E)-␣,␤-dehydro-3,4-dihydroxyphenylalanine. Although the sequence of plicatamide did not resemble a conventional antimicrobial peptide, we examined its antimicrobial properties because hemocytes are key participants in innate antimicrobial defenses. Despite its small size, plicatamide proved to be a potent, rapidly acting, and broad spectrum antimicrobial. We also prepared the following four synthetic analogues that differed from plicatamide only in their C-terminal residue: tyrosine amide in PL-101; tyrosine acid in PL-102; DOPA (3,4-dihydroxyphenylalanine) acid in PL-103; and DOPA-amide in PL-104. Of these octapeptides, PL-101 most closely simulated the antimicrobial properties of native plicatamide. This report will describe the effects of plicatamide on staphylococci. MATERIALS AND METHODS Peptide PurificationNative plicatamide was purified from freshly harvested hemocytes (blood cells) of S. plicata as described recently (1). We determined their peptide content either by performing quantitative amino acid analysis or by doing analytical reverse phase-HPLC on a C18 column and then computing and comparing the area under the curve (AUC) at 215 nm with the AUC of an appropriate standard previously subjected to quantitative amino acid analysis. Peptide SynthesisThe synthetic peptides used in our initial experiments were customsynthesized by Fmoc (N-(9-fluorenyl)methoxycarbonyl) chemistry at Research Genetics (Huntsville, AL) and puri...

No abstract

A modified pentapeptide has been isolated from the hemocytes of the ascidian Styela plicata. The structure of the peptide was determined by Edman sequence analysis, mass spectrometry, and NMR spectroscopy with the stereochemistry assigned by acid hydrolysis followed by both (a) GC-MS of the volatile amino acid derivatives on a chiral column and (b) ultrasensitive detection of fluorescent diasteromeric derivatives of the component amino acids after reversed-phase HPLC. The peptide L-DOPA-L-DOPA-Gly-L-Pro-dcdeltaDOPA (where DOPA = 3,4-dihydroxyphenylalanine and dcdeltaDOPA = decarboxy-(E)-alpha,beta-dehydro-3,4-dihydroxyphenylalanine) we designate as tunichrome Sp-1.

Tunichrome Sp-1 is a modified pentapeptide from the ascidian Styela plicata, having the structure H-DOPA-DOPA-Gly-Pro-dcDeltaDOPA (where DOPA = 3,4-dihydroxyphenylalanine and dcDeltaDOPA = decarboxy-(E)-alpha,beta-dehydro-DOPA). The tandem mass spectrum of the peptide is dominated by a number of abundant fragment ions that involve a gas-phase rearrangement where the dcDeltaDOPA group becomes covalently attached to the N-terminus. The high degree of rearrangement in Sp-1 compared with a related octapeptide, plicatamide, allowed for detailed multiple mass spectrometric (MS(n)) (up to n = 6) experiments, and hence permitted a detailed assessment of the origin and routes to the formation of the various rearrangement ions. Analyses on both a triple-quadrupole and a quadrupole time-of-flight mass spectrometer were made to ascertain whether the gas-phase rearrangements observed for tunichrome Sp-1 were unique to an ion trap mass spectrometer (i.e. the hypothesis being that perhaps the extended trapping times were required to facilitate this unusual gas-phase rearrangement). Interestingly, analyses on both the triple-quadrupole and quadruple time-of-flight mass spectrometers revealed an identical phenomenon, with the rearrangement fragment ions present at approximately the same abundance as the non-rearranged a-, b- and y-type sequence ions. We suggest that the smaller size of tunichrome Sp-1 compared with plicatamide facilitates the transfer of the dcDeltaDOPA group in this gas-phase rearrangement. This rearrangement was not observed for peptide analogs of tunichrome Sp-1 that did not contain the dcDeltaDOPA at the C-terminus, confirming that the presence of dcDeltaDOPA is critical for the rearrangement.